Literature DB >> 7858260

Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas.

J C Renauld1, A Vink, J Louahed, J Van Snick.   

Abstract

We have recently shown that interleukin-9 (IL-9) strongly stimulates the proliferation of mouse thymic lymphomas in vitro. Here we report that this factor is also one of the most potent inhibitors of apoptosis induced by dexamethasone (DEX) in such cell lines, even if they do not depend on exogenous factors for growth. For the murine thymic lymphoma BW5147, protection against apoptosis was also obtained with IL-4 and less strongly with IL-6, whereas IL-2, IL-7, and IL-10 were inactive. Moreover, IL-4 and IL-9 maintained proliferation of these cells in the presence of DEX. Analysis of eight other factor-independent thymic lymphoma lines showed significant protection in seven and six cell lines with IL-9 and IL-4, respectively, whereas only three were protected by IL-7 and only two by IL-2. Comparison of the responses to IL-2 and IL-9 in a factor-dependent cell line that responds to both cytokines showed that IL-2 is a stronger inducer of proliferation, while IL-9 is more efficient in protecting the cells against apoptosis. Taken together, our observations suggest that, for thymic lymphomas, proliferation and apoptosis involve distinct regulatory mechanisms and can be differentially regulated by cytokines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7858260

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  IL-9 and Th9 cells: progress and challenges.

Authors:  Picheng Zhao; Xiang Xiao; Rafik M Ghobrial; Xian C Li
Journal:  Int Immunol       Date:  2013-09-11       Impact factor: 4.823

2.  Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections.

Authors:  P G Fallon; P Smith; E J Richardson; F J Jones; H C Faulkner; J Van Snick; J C Renauld; R K Grencis; D W Dunne
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.

Authors:  Dana N Mitzel; Richard J Jaramillo; Heather Stout-Delgado; Albert P Senft; Kevin S Harrod
Journal:  J Gen Virol       Date:  2013-10-10       Impact factor: 3.891

4.  Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Authors:  Katherine E Olson; Aditya N Bade; Krista L Namminga; Mary Jane Potash; R Lee Mosley; Larisa Y Poluektova; David J Volsky; Howard E Gendelman
Journal:  J Neurovirol       Date:  2018-03-28       Impact factor: 2.643

Review 5.  The dichotomous function of interleukin-9 in cancer diseases.

Authors:  K Gerlach; B Weigmann
Journal:  J Mol Med (Berl)       Date:  2019-08-08       Impact factor: 4.599

6.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

7.  Role of high expression of IL-9 in prognosis of CLL.

Authors:  Na Chen; Xiao Lv; Peipei Li; Kang Lu; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 8.  Th9 and allergic disease.

Authors:  Pejman Soroosh; Taylor A Doherty
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

9.  Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?

Authors:  E W Baxter; K Blyth; L A Donehower; E R Cameron; D E Onions; J C Neil
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.

Authors:  Tekla Hornakova; Judith Staerk; Yohan Royer; Elisabetta Flex; Marco Tartaglia; Stefan N Constantinescu; Laurent Knoops; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.